Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Novo (NVO) offers injector pen versions of its weight loss therapy semaglutide marketed as Wegovy at $650 for a month’s supply, and the Danish drugmaker doesn’t sell the GLP-1 in vial formats.

Zepbound sales in the fourth quarter reached $1.91 billion, up from $175.8 million a year ago. Annual sales reached $4.93 billion. In August 2024, Eli Lilly released vials containing low doses of ...

Six months after Eli Lilly began selling discounted vials of its blockbuster weight loss drug Zepbound, the company expanded the offering Feb. 25 to include cheaper, high-dose Zepbound vials.

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials. Glenmark's Acetylcysteine Injection, 6 gm/30 ...